LATEST NEWS

Nanoparticle-enhanced radiotherapy combined with triple blockade of PD1, LAG3, and TIGIT enhances anti-tumor immune activation

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.